M1774 in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors
Condition: Metastatic or Locally Advanced Unresectable Solid Tumors Intervention: Drug: M1774 Sponsors: EMD Serono Research & Development Institute, Inc.; Merck KGaA, Darmstadt, Germany Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Germany Health | Research